Prudential Financial Inc Immuno Gen, Inc. Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$12.46 - $29.95 $752,920 - $1.81 Million	-60,427 Reduced 76.83%	18,221 $540,000
Q3 2023 Nov 13, 2023	SELL	$14.09 - $19.87 $2.71 Million - $3.82 Million	-192,246 Reduced 70.97%	78,648 $1.25 Million
Q2 2023 Aug 11, 2023	SELL	$3.75 - $20.05 $1.56 Million - $8.32 Million	-414,881 Reduced 60.5%	270,894 $5.11 Million
Q1 2023 May 12, 2023	SELL	$3.67 - $4.92 $1.64 Million - $2.2 Million	-446,303 Reduced 39.42%	685,775 $2.63 Million
Q4 2022 Feb 14, 2023	SELL	$4.55 - $6.31 $133,387 - $184,983	-29,316 Reduced 2.52%	1,132,078 $0
Q3 2022 Nov 04, 2022	BUY	$4.48 - $6.47 $4.44 Million - $6.42 Million	991,712 Added 584.45%	1,161,394 $5.55 Million
Q2 2022 Aug 15, 2022	BUY	$3.15 - $5.76 $479,959 - $877,639	152,368 Added 880.03%	169,682 $764,000
Q1 2022 May 13, 2022	BUY	$4.26 - $7.48 $1,840 - $3,231	432 Added 2.56%	17,314 $83,000
Q4 2021 Feb 14, 2022	SELL	$4.75 - $7.5 $2,299 - $3,630	-484 Reduced 2.79%	16,882 $115,000
Q3 2021 Nov 15, 2021	BUY	$5.02 - $6.59 $4,753 - $6,240	947 Added 5.77%	17,366 $101,000
Q2 2021 Aug 16, 2021	BUY	$5.79 - $8.6 $2,391 - $3,551	413 Added 2.58%	16,419 $108,000
Q1 2021 May 12, 2021	BUY	$6.5 - $10.53 $3,763 - $6,096	579 Added 3.75%	16,006 $130,000
Q4 2020 Feb 16, 2021	BUY	$3.7 - $7.66 $53,032 - $109,790	14,333 Added 1310.15%	15,427 $100,000
Q3 2020 Aug 05, 2021	SELL	$3.45 - $4.89 $40,806 - $57,838	-11,828 Reduced 91.53%	1,094 $4,000
Q3 2020 Nov 16, 2020	BUY	$3.45 - $4.89 $40,810 - $57,843	11,829 Added 1082.25%	12,922 $47,000
Q2 2020 Aug 05, 2021	SELL	$3.32 - $5.34 $40,035 - $64,395	-12,059 Reduced 91.69%	1,093 $5,000
Q2 2020 Aug 12, 2020	BUY	$3.32 - $5.34 $43,090 - $69,307	12,979 Added 7502.31%	13,152 $60,000
Q1 2020 Aug 05, 2021	SELL	$2.12 - $6.8 $26,603 - $85,333	-12,549 Reduced 98.64%	173 $1,000
Q1 2020 May 12, 2020	BUY	$2.12 - $6.8 $26,557 - $85,183	12,527 Added 6424.1%	12,722 $43,000
Q4 2019 Aug 05, 2021	SELL	$2.25 - $5.8 $27,645 - $71,264	-12,287 Reduced 98.44%	195 $1,000
Q4 2019 Feb 11, 2020	BUY	$2.25 - $5.8 $27,645 - $71,264	12,287 Added 6301.03%	12,482 $63,000
Q3 2019 Aug 05, 2021	SELL	$2.22 - $3.39 $25,989 - $39,686	-11,707 Reduced 98.36%	195 $0
Q3 2019 Nov 13, 2019	BUY	$2.22 - $3.39 $26,053 - $39,785	11,736 Added 7069.88%	11,902 $28,000
Q2 2019 Aug 05, 2021	SELL	$1.8 - $3.3 $25,336 - $46,450	-14,076 Reduced 98.83%	166 $0
Q2 2019 Aug 08, 2019	BUY	$1.8 - $3.3 $2,286 - $4,191	1,270 Added 9.79%	14,242 $0
Q1 2019 May 15, 2019	SELL	$2.41 - $5.91 $530 - $1,300	-220 Reduced 1.67%	12,972 $0
Q4 2018 Feb 07, 2019	SELL	$3.94 - $9.7 $2,718 - $6,692	-690 Reduced 4.97%	13,192 $63,000
Q3 2018 Nov 07, 2018	SELL	$8.6 - $11.26 $76,712 - $100,439	-8,920 Reduced 39.12%	13,882 $0
Q2 2018 Aug 13, 2018	BUY	$9.52 - $12.15 $217,075 - $277,044	22,802 New	22,802 $0

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account